In this issue of Clinics in Perinatology, guest editors Drs. Satyanarayana Lakshminrusimha and Steve Abman bring their considerable expertise to the topic of Neonatal Pulmonary Hypertension. About one in every 1,250 newborns develop neonatal pulmonary hypertension, and about 25% of survivors will have developmental delays, hearing problems, and/or functional disabilities. In this issue, top experts provide updates to the perinatologist on managing this condition to improve patient outcomes.
Pulmonary Vascular Regulation in the Fetal and Transitional Lung Pathogenesis and Physiologic Mechanisms of Neonatal Pulmonary Hypertension: Preclinical Studies Targeted Neonatal Echocardiography in the Management of Neonatal Pulmonary Hypertension Oxygen Targets in Neonatal Pulmonary Hypertension: Individualized, Precision[1]Medicine” Approach Inhaled Nitric Oxide in Neonatal Pulmonary Hypertension Targeted Therapies for Neonatal Pulmonary Hypertension: Beyond Nitric Oxide Asphyxia, Therapeutic Hypothermia, and Pulmonary Hypertension Congenital Diaphragmatic Hernia: Pulmonary Hypertension and Pulmonary Vascular Disease Early Pulmonary Hypertension in Preterm Infants Pulmonary Hypertension in Established Bronchopulmonary Dysplasia: Physiologic Approaches to Clinical Care Pulmonary Hypertension in Developmental Lung Diseases Etiology, Diagnosis and Management of Persistent Pulmonary Hypertension of the Newborn in Resource-limited Settings Randomized Controlled Trials of Pulmonary Vasodilator Therapy Adjunctive to Inhaled Nitric Oxide for Persistent Pulmonary Hypertension of the Newborn: A Systematic Review Comorbidities and Late Outcomes in Neonatal Pulmonary Hypertension
Komentarze (0)
Chwilowo nie możesz polubić tej opinii
Zgłoś komentarz
Czy jesteś pewien, że chcesz zgłosić ten komentarz?
Zgłoszenie wysłane
Twój komentarz został wysłany i będzie widoczny po zatwierdzeniu przez moderatora.